Skip to main content

Table 4 Antioxidative status in the study groups

From: Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study

 

CRF

HD

PD

SOD (U.ml-1)

82.10 ± 1.53

70.08 ± 4.20*

80.12 ± 0.38#

GSH-Px (U.ml-1)

5.92 ± 0.53

4.12 ± 0.3*

4.08 ± 0.06*

Catalase (U.ml-1)

85.45 ± 4.74

80.18 ± 1.32

65.78 ± 3.45**#

Nitric oxide (μmol.L-1)

22.53 ± 7.24

30.57 ± 8.7*

20.52 ± 1.58

Albumins (g.L-1)

32.95 ± 0.25

30.78 ± 1.18*

29.50 ± 0.07*

Urate (μmol/L)

513.94 ± 171.61

382.09 ± 66.07***

349.63 ± 167.2***

Bilirubin (μmol/L)

6.29 ± 2.60

5.01 ± 0.60

8.39 ± 6.76

Iron (μmol/L)

33.08 ± 7.71

55.17 ± 1.53 ***

40.59 ± 3.07###

CRP (mg L-1)

6.5 ± 0.2

8.2 ± 0.2*

8.8 ± 0.8*

  1. CRF: End stage chronic renal failure patients. HD: patients on hemodialysis. PD: Patients on peritoneal dialysis. Data are presented as the mean ± SD. * HD group and PD group vs CRF group # HD group vs PD group. *# (P < 0.05); **(P < 0.01); ***###(P < 0.001)